表紙:幹細胞製造の世界市場 (~2026年):製品 (消耗品・機器・HSC・MSC・iPSC・ESC)・用途 (研究・臨床 (自家・同種)・細胞&組織バンク)・エンドユーザー (製薬&バイオテクノロジー・病院・組織バンク)・地域別
市場調査レポート
商品コード
1007223

幹細胞製造の世界市場 (~2026年):製品 (消耗品・機器・HSC・MSC・iPSC・ESC)・用途 (研究・臨床 (自家・同種)・細胞&組織バンク)・エンドユーザー (製薬&バイオテクノロジー・病院・組織バンク)・地域別

Stem Cell Manufacturing Market by Product (Consumables, Instrument, HSCs, MSCs, iPSCs, ESCs), Application (Research, Clinical (Autologous, Allogenic), Cell & Tissue Banking), End User (Pharma & Biotech, Hospitals, Tissue Bank) - Global Forecast to 2026

出版日: | 発行: MarketsandMarkets | ページ情報: 英文 284 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.77円
幹細胞製造の世界市場 (~2026年):製品 (消耗品・機器・HSC・MSC・iPSC・ESC)・用途 (研究・臨床 (自家・同種)・細胞&組織バンク)・エンドユーザー (製薬&バイオテクノロジー・病院・組織バンク)・地域別
出版日: 2021年05月18日
発行: MarketsandMarkets
ページ情報: 英文 284 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

幹細胞製造の市場規模は予測期間中9.4%のCAGRで推移し、2021年の115憶米ドルから、2026年には180億米ドルの規模に成長すると予測されています。

幹細胞を用いた研究への投資の拡大、幹細胞製品の治療効果に対する認識の拡大、新興諸国における規制の枠組みなどの要因が同市場の成長を推進しています。

製品別では、消耗品の部門が最大のシェアを示しています。消耗品の購入頻度の高さ、幹細胞研究の拡大、幹細胞治療への需要の増加などの要因が同部門の成長を牽引しています。

当レポートでは、世界の幹細胞製造の市場を調査し、市場の定義と概要、バリューチェーン、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、法規制環境、技術・特許の動向、市場規模の推移・予測、製品・用途・エンドユーザー・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
    • 課題
  • COVID-19の影響
  • ポーターのファイブフォース分析
  • バリューチェーン分析
  • サプライチェーン分析
  • 技術分析
  • エコシステム分析
  • 特許分析
  • 価格分析
  • 規制分析

第6章 市場分析・予測:製品別

  • 消耗品
    • 培地
    • その他
  • 機器
    • バイオリアクター・インキュベーター
    • セルソーター
    • その他
  • 幹細胞株
    • 造血幹細胞
    • 間葉系幹細胞
    • 人工多能性幹細胞
    • 胚性幹細胞
    • 神経幹細胞
    • 多能性成人前駆細胞幹細胞

第7章 市場分析・予測:用途別

  • 研究
    • ライフサイエンス研究
    • 創薬・開発
  • 臨床応用
    • 同種幹細胞治療
    • 自家幹細胞治療
  • 細胞・組織バンク

第8章 市場分析・予測:エンドユーザー別

  • 製薬・バイオテクノロジー企業
  • 学術機関・研究・委託研究機関
  • 病院・外科センター
  • 細胞・組織バンク
  • その他

第9章 市場分析・予測:地域・主要国別

  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第10章 競合情勢

  • 概要
  • 主要企業の戦略
  • 市場シェア分析
  • 主要企業の収益シェア分析
  • 企業評価クアドラント
  • 企業評価クアドラント:新興企業/中小企業
  • 企業製品フットプリント
  • 企業の地理的フットプリント
  • 市場評価フレームワーク
  • 競合シナリオ

第11章 企業プロファイル

  • 主要企業
    • THERMO FISHER SCIENTIFIC
    • MERCK MILLIPORE
    • LONZA GROUP
    • DANAHER CORPORATION
    • SARTORIUS AG
    • BECTON, DICKINSON AND COMPANY
    • EPPENDORF AG
    • CORNING INC.
    • BIO-RAD LABORATORIES
    • TAKARA BIO GROUP
    • FUJIFILM HOLDINGS CORPORATION
    • GETINGE AB
    • TERUMO CORPORATION
    • BIO-TECHNE CORPORATION
    • HIMEDIA LABORATORIES
  • その他の企業
    • STEMCELL TECHNOLOGIES INC.
    • MILTENYI BIOTEC GMBH
    • PROMOCELL
    • ANTEROGEN CO., LTD.
    • CELLGENIX GMBH

第12章 付録

目次
Product Code: BT 6089

The Stem Cell Manufacturing market is projected to reach USD 18.0 billion by 2026 from USD 11.5 billion in 2021, at a CAGR of 9.4% during the forecast period, owing to the growing investments in stem cell-based research, rising awareness about the therapeutic potency of stem cell products, and supportive regulatory framework across developing countries.

"By product, the consumables segment accounted for the largest share of the Stem Cell Manufacturing market"

The Stem Cell Manufacturing market by product is categorized into consumables, instruments, and stem cell lines. The consumables segment dominated the market in 2020. The large share of this segment can be attributed to the frequent purchase of consumables, rising stem cell research, and increasing demand for stem cell therapies.

"Asia Pacific: The fastest-growing region in the Stem Cell Manufacturing market."

The Asia Pacific market is projected to grow at the highest CAGR during the forecast period, mainly due to supportive regulatory framework and increasing public-private initiatives to encourage public awareness about stem cell-based treatments.

"North America: the largest share of the Stem Cell Manufacturing market"

North America accounted for the largest share of the Stem Cell Manufacturing market. Factors such as private funding and grants to support the clinical evaluation of stem cells for various applications are the major factors driving the market growth.

Breakdown of primaries

The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:

  • By Respondent- Supply Side- 63%, Demand Side- 37%
  • By Designation- Executives- 25%, CXOs, Directors--30%, Managers - 45%
  • By Region- North America - 40%, Europe - 25%, APAC - 20%, LATAM- 10%, MEA- 5%

The Stem Cell Manufacturing market is dominated by a few globally established players such as Thermo Fisher Scientific (US), Merck Millipore (Germany), Lonza Group AG (Switzerland), Danaher Corporation (US), Sartorius AG (Germany), Bio-Rad Laboratories (US), Becton, Dickinson and Company (US), Stemcell Technologies (Canada), Fujifilm Holdings Corporation (Japan), Miltenyi Biotec (Germany), Terumo BCT Inc. (US), Corning Inc. (US), Bio-Techne Corporation (US), Takara Bio Group (Japan), Eppendorf AG (Germany), Getinge (Sweden), Himedia Laboratories (India), Anterogen (South Korea), Cellgenix GMBH (Germany) and Promocell (Germany).

Research Coverage:

The report segments the Stem Cell Manufacturing market-based on region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa), Product [Consumables (Culture Media and other consumables), Instruments (Bioreactors & Incubators, Cell Sorters and other instruments) and Stem Cell Lines (Hematopoietic stem cells, Mesenchymal stem cells, Induced Pluripotent Stem cells, Embryonic stem cells, Neural Stem cells and Multipotent adult progenitor stem cells)], Application [Research (Life science research and Drug discovery and development), Clinical (Allogenic stem cell therapy and Autologous stem cell therapy) and Cell & Tissue Banking Applications], End User (Pharmaceutical & Biotechnology Companies, Academic institutes, Research laboratories & contract research organisations, Hospitals and surgical centres, Cell & tissue banks and Other End Users).

The report also provides a comprehensive review of market drivers, challenges, and opportunities in the Stem Cell Manufacturing market

Key Benefits of Buying the Report:

The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the Stem Cell Manufacturing market and provides them information on key market drivers, challenges, and opportunities.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
  • 1.3 MARKET SCOPE
    • FIGURE 1 STEM CELL MANUFACTURING MARKET SEGMENTATION
    • 1.3.1 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
    • 2.1.2 PRIMARY DATA
    • FIGURE 2 PRIMARY SOURCES
    • FIGURE 3 STEM CELL MANUFACTURING MARKET: BREAKDOWN OF PRIMARIES
      • 2.1.2.1 Key industry insights
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 - REVENUE SHARE ANALYSIS, 2020
    • FIGURE 5 AVERAGE MARKET SIZE ESTIMATION, 2020
    • FIGURE 6 STEM CELL MANUFACTURING MARKET: CAGR PROJECTIONS, 2021-2026
    • FIGURE 7 STEM CELL MANUFACTURING MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 8 DATA TRIANGULATION METHODOLOGY
  • 2.4 RESEARCH ASSUMPTIONS
  • 2.5 RISK ANALYSIS

3 EXECUTIVE SUMMARY

    • FIGURE 9 STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
    • FIGURE 10 STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
    • FIGURE 11 STEM CELL MANUFACTURING MARKET, BY END USER 2021 VS. 2026 (USD MILLION)
    • FIGURE 12 GEOGRAPHICAL SNAPSHOT: STEM CELL MANUFACTURING MARKET

4 PREMIUM INSIGHTS

  • 4.1 STEM CELL MANUFACTURING MARKET OVERVIEW
    • FIGURE 13 GROWING INVESTMENTS IN STEM CELL-BASED RESEARCH TO DRIVE MARKET GROWTH
  • 4.2 NORTH AMERICA: STEM CELL MANUFACTURING MARKET SHARE, BY PRODUCT & COUNTRY (2020)
    • FIGURE 14 CONSUMABLES ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN STEM CELL MANUFACTURING MARKET IN 2020
  • 4.3 STEM CELL MANUFACTURING MARKET SHARE, BY END USER, 2020
    • FIGURE 15 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2020
  • 4.4 STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
    • FIGURE 16 RESEARCH APPLICATIONS WILL CONTINUE TO DOMINATE THE APPLICATIONS MARKET
  • 4.5 STEM CELL MANUFACTURING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 17 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH IN THE STEM CELL MANUFACTURING MARKET FROM 2021 TO 2026

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • TABLE 1 STEM CELL MANUFACTURING MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing venture capital investments in stem cell research
      • 5.2.1.2 Increasing awareness about the therapeutic potency of stem cell products
      • 5.2.1.3 Technological advancements in stem cell manufacturing
      • 5.2.1.4 Increasing incidence of cancer and collaborative efforts in cancer research
    • TABLE 2 GLOBAL CANCER INCIDENCE, 2020 VS. 2040
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Significant operational costs associated with stem cell manufacturing and banking
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Supportive regulatory framework across developing countries
      • 5.2.3.2 Government initiatives to boost the biotechnology and biopharmaceutical industries
      • 5.2.3.3 Increased market focus on mesenchymal stem cells and induced pluripotent stem cells
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Technical limitations associated with manufacturing scale-up
      • 5.2.4.2 Socio-ethical concerns related to the use of allogeneic and human embryonic stem cells
  • 5.3 IMPACT OF THE COVID-19 PANDEMIC ON THE STEM CELL MANUFACTURING MARKET
    • 5.3.1 INTRODUCTION
    • 5.3.2 SUPPLY CHAIN
    • 5.3.3 RESEARCH & DEVELOPMENT
    • FIGURE 18 CLINICAL TRIALS FOR COVID-19 USING STEM CELLS, BY REGION
    • 5.3.4 RESEARCH FUNDING
  • 5.4 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 3 STEM CELL MANUFACTURING MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.4.1 THREAT OF NEW ENTRANTS
    • 5.4.2 THREAT OF SUBSTITUTES
    • 5.4.3 BARGAINING POWER OF SUPPLIERS
    • 5.4.4 BARGAINING POWER OF BUYERS
    • 5.4.5 DEGREE OF COMPETITION
  • 5.5 VALUE CHAIN ANALYSIS
    • FIGURE 19 VALUE CHAIN ANALYSIS OF THE STEM CELL MANUFACTURING MARKET: RAW MATERIAL, MANUFACTURING, & ASSEMBLY PHASES ADD MAXIMUM VALUE
  • 5.6 SUPPLY CHAIN ANALYSIS
    • FIGURE 20 STEM CELL MANUFACTURING MARKET: SUPPLY CHAIN ANALYSIS
  • 5.7 TECHNOLOGY ANALYSIS
    • 5.7.1 BIOREACTORS
    • TABLE 4 SINGLE-USE BIOREACTORS VS. STAINLESS-STEEL BIOREACTORS
    • 5.7.2 CELL CULTURE MEDIA
    • 5.7.3 CELL IMAGING SYSTEMS
  • 5.8 ECOSYSTEM ANALYSIS
    • FIGURE 21 ECOSYSTEM ANALYSIS: STEM CELL MANUFACTURING MARKET
    • TABLE 5 ECOSYSTEM ANALYSIS
  • 5.9 PATENT ANALYSIS
    • FIGURE 22 PATENT APPLICATIONS FOR STEM CELL MANUFACTURING, JANUARY 2010-DECEMBER 2020
  • 5.10 PRICING ANALYSIS
    • TABLE 6 AVERAGE SELLING PRICE OF LAB-SCALE SINGLE-USE BIOREACTORS, BY REGION (2020)
    • TABLE 7 AVERAGE SELLING PRICE OF STEM CELL LINES (USD), BY REGION (2020)
  • 5.11 REGULATORY ANALYSIS
    • 5.11.1 REGULATORY ANALYSIS FOR STEM CELL MANUFACTURING PRODUCTS
      • 5.11.1.1 North America
        • 5.11.1.1.1 US
    • TABLE 8 US FDA: MEDICAL DEVICE CLASSIFICATION
    • TABLE 9 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
        • 5.11.1.1.2 Canada
      • 5.11.1.2 Europe
    • 5.11.2 REGULATORY ANALYSIS FOR STEM CELL THERAPY PRODUCTS
      • 5.11.2.1 US
      • 5.11.2.2 European Union

6 STEM CELL MANUFACTURING MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
    • TABLE 10 STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
  • 6.2 CONSUMABLES
    • TABLE 11 STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 12 STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 13 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 14 EUROPE: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 15 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY COUNTRY, 2019-2026 (USD MILLION)
    • 6.2.1 CULTURE MEDIA
      • 6.2.1.1 Rising stem cell research and increasing demand for stem cell therapies will contribute to the adoption of culture media
    • TABLE 16 STEM CELL MANUFACTURING MARKET FOR CULTURE MEDIA, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 17 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR CULTURE MEDIA, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 18 EUROPE: STEM CELL MANUFACTURING MARKET FOR CULTURE MEDIA, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 19 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR CULTURE MEDIA, BY COUNTRY, 2019-2026 (USD MILLION)
    • 6.2.2 OTHER CONSUMABLES
    • TABLE 20 STEM CELL MANUFACTURING MARKET FOR OTHER CONSUMABLES, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 21 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 22 EUROPE: STEM CELL MANUFACTURING MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 23 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2019-2026 (USD MILLION)
  • 6.3 INSTRUMENTS
    • TABLE 24 STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 25 STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 26 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 27 EUROPE: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 28 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY COUNTRY, 2019-2026 (USD MILLION)
    • 6.3.1 BIOREACTORS & INCUBATORS
      • 6.3.1.1 The introduction of advanced bioreactors and incubators is contributing to market growth
    • TABLE 29 STEM CELL MANUFACTURING MARKET FOR BIOREACTORS & INCUBATORS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 30 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR BIOREACTORS & INCUBATORS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 31 EUROPE: STEM CELL MANUFACTURING MARKET FOR BIOREACTORS & INCUBATORS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 32 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR BIOREACTORS & INCUBATORS, BY COUNTRY, 2019-2026 (USD MILLION)
    • 6.3.2 CELL SORTERS
      • 6.3.2.1 Growth can be attributed to the development of novel cell sorting technologies such as microfluidics
    • TABLE 33 STEM CELL MANUFACTURING MARKET FOR CELL SORTERS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 34 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR CELL SORTERS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 35 EUROPE: STEM CELL MANUFACTURING MARKET FOR CELL SORTERS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 36 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR CELL SORTERS, BY COUNTRY, 2019-2026 (USD MILLION)
    • 6.3.3 OTHER INSTRUMENTS
    • TABLE 37 STEM CELL MANUFACTURING MARKET FOR OTHER INSTRUMENTS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 38 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 39 EUROPE: STEM CELL MANUFACTURING MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 40 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2019-2026 (USD MILLION)
  • 6.4 STEM CELL LINES
    • TABLE 41 STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 42 STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 43 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 44 EUROPE: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 45 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY COUNTRY, 2019-2026 (USD MILLION)
    • 6.4.1 HEMATOPOIETIC STEM CELLS
      • 6.4.1.1 Growth is driven by the increasing adoption of cord blood banking
    • TABLE 46 HEMATOPOIETIC STEM CELLS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 47 NORTH AMERICA: HEMATOPOIETIC STEM CELLS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 48 EUROPE: HEMATOPOIETIC STEM CELLS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 49 ASIA PACIFIC: HEMATOPOIETIC STEM CELLS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • 6.4.2 MESENCHYMAL STEM CELLS
      • 6.4.2.1 Ease of cell harvesting, processing, and preservation drives the adoption of MSCs
    • TABLE 50 MESENCHYMAL STEM CELLS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 51 NORTH AMERICA: MESENCHYMAL STEM CELLS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 52 EUROPE: MESENCHYMAL STEM CELLS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 53 ASIA PACIFIC: MESENCHYMAL STEM CELLS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • 6.4.3 INDUCED PLURIPOTENT STEM CELLS
      • 6.4.3.1 Growth can be attributed to the increased adoption of iPSCs in research on cell therapies & regenerative medicine
    • TABLE 54 INDUCED PLURIPOTENT STEM CELLS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 55 NORTH AMERICA: INDUCED PLURIPOTENT STEM CELLS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 56 EUROPE: INDUCED PLURIPOTENT STEM CELLS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 57 ASIA PACIFIC: INDUCED PLURIPOTENT STEM CELLS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • 6.4.4 EMBRYONIC STEM CELLS
      • 6.4.4.1 Rising research activity in cancer precision medicine contributes to segmental growth
    • TABLE 58 EMBRYONIC STEM CELLS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 59 NORTH AMERICA: EMBRYONIC STEM CELLS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 60 EUROPE: EMBRYONIC STEM CELLS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 61 ASIA PACIFIC: EMBRYONIC STEM CELLS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • 6.4.5 NEURAL STEM CELLS
      • 6.4.5.1 The introduction of novel isolation and expansion techniques for NSCs will drive the market
    • TABLE 62 NEURAL STEM CELLS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 63 NORTH AMERICA: NEURAL STEM CELLS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 64 EUROPE: NEURAL STEM CELLS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 65 ASIA PACIFIC: NEURAL STEM CELLS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • 6.4.6 MULTIPOTENT ADULT PROGENITOR STEM CELLS
      • 6.4.6.1 Rising awareness of the role of MAPCs in research
    • TABLE 66 MULTIPOTENT ADULT PROGENITOR STEM CELLS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 67 NORTH AMERICA: MULTIPOTENT ADULT PROGENITOR STEM CELLS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 68 EUROPE: MULTIPOTENT ADULT PROGENITOR STEM CELLS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 69 ASIA PACIFIC: MULTIPOTENT ADULT PROGENITOR STEM CELLS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)

7 STEM CELL MANUFACTURING MARKET, BY APPLICATION

  • 7.1 INTRODUCTION
    • TABLE 70 STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
  • 7.2 RESEARCH APPLICATIONS
    • TABLE 71 STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 72 STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 73 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 74 EUROPE: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 75 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
    • 7.2.1 LIFE SCIENCE RESEARCH
      • 7.2.1.1 Market growth is driven by the increasing research focus on stem cell cytology & pathology
    • TABLE 76 STEM CELL MANUFACTURING MARKET FOR LIFE SCIENCE RESEARCH, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 77 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR LIFE SCIENCE RESEARCH, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 78 EUROPE: STEM CELL MANUFACTURING MARKET FOR LIFE SCIENCE RESEARCH, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 79 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR LIFE SCIENCE RESEARCH, BY COUNTRY, 2019-2026 (USD MILLION)
    • 7.2.2 DRUG DISCOVERY & DEVELOPMENT
      • 7.2.2.1 Increasing research expenditure by pharma and biotech companies will contribute to market growth
    • TABLE 80 STEM CELL MANUFACTURING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 81 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 82 EUROPE: STEM CELL MANUFACTURING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 83 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2019-2026 (USD MILLION)
  • 7.3 CLINICAL APPLICATIONS
    • TABLE 84 STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 85 STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 86 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 87 EUROPE: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 88 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
    • 7.3.1 ALLOGENEIC STEM CELL THERAPY
      • 7.3.1.1 Wide therapeutic applications of stem cell lines to drive growth
    • TABLE 89 STEM CELL MANUFACTURING MARKET FOR ALLOGENEIC STEM CELL THERAPY, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 90 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR ALLOGENEIC STEM CELL THERAPY, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 91 EUROPE: STEM CELL MANUFACTURING MARKET FOR ALLOGENEIC STEM CELL THERAPY, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 92 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR ALLOGENEIC STEM CELL THERAPY, BY COUNTRY, 2019-2026 (USD MILLION)
    • 7.3.2 AUTOLOGOUS STEM CELL THERAPY
      • 7.3.2.1 Increasing patient preference for autologous stem cell therapy will drive segmental growth
    • TABLE 93 STEM CELL MANUFACTURING MARKET FOR AUTOLOGOUS STEM CELL THERAPY, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 94 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR AUTOLOGOUS STEM CELL THERAPY, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 95 EUROPE: STEM CELL MANUFACTURING MARKET FOR AUTOLOGOUS STEM CELL THERAPY, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 96 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR AUTOLOGOUS STEM CELL THERAPY, BY COUNTRY, 2019-2026 (USD MILLION)
  • 7.4 CELL & TISSUE BANKING APPLICATIONS
    • 7.4.1 RISING DEMAND FOR CORD BLOOD STEM CELL BANKING INDICATES FAVORABLE PROSPECTS
    • TABLE 97 STEM CELL MANUFACTURING MARKET FOR CELL & TISSUE BANKING APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 98 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR CELL & TISSUE BANKING APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 99 EUROPE: STEM CELL MANUFACTURING MARKET FOR CELL & TISSUE BANKING APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 100 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR CELL & TISSUE BANKING APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)

8 STEM CELL MANUFACTURING MARKET, BY END USER

  • 8.1 INTRODUCTION
    • TABLE 101 STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 8.2.1 GROWTH IS DRIVEN BY INCREASING PRIVATE INVESTMENTS FOR STEM CELL-BASED RESEARCH
    • TABLE 102 STEM CELL MANUFACTURING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 103 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 104 EUROPE: STEM CELL MANUFACTURING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 105 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019-2026 (USD MILLION)
  • 8.3 ACADEMIC INSTITUTES, RESEARCH LABORATORIES, AND CONTRACT RESEARCH ORGANIZATIONS
    • 8.3.1 MARKET GROWTH IS DRIVEN BY INCREASED PUBLIC FUNDING FOR RESEARCH ACTIVITIES
    • TABLE 106 STEM CELL MANUFACTURING MARKET FOR ACADEMIC INSTITUTES, RESEARCH LABORATORIES, AND CROS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 107 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR ACADEMIC INSTITUTES, RESEARCH LABORATORIES, AND CROS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 108 EUROPE: STEM CELL MANUFACTURING MARKET FOR ACADEMIC INSTITUTES, RESEARCH LABORATORIES, AND CROS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 109 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR ACADEMIC INSTITUTES, RESEARCH LABORATORIES, AND CROS, BY COUNTRY, 2019-2026 (USD MILLION)
  • 8.4 HOSPITALS & SURGICAL CENTERS
    • 8.4.1 GROWTH CAN BE ATTRIBUTED TO IMPROVED HEALTHCARE INFRASTRUCTURE
    • TABLE 110 STEM CELL MANUFACTURING MARKET FOR HOSPITALS & SURGICAL CENTERS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 111 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR HOSPITALS & SURGICAL CENTERS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 112 EUROPE: STEM CELL MANUFACTURING MARKET FOR HOSPITALS & SURGICAL CENTERS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 113 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR HOSPITALS & SURGICAL CENTERS, BY COUNTRY, 2019-2026 (USD MILLION)
  • 8.5 CELL & TISSUE BANKS
    • 8.5.1 GROWING APPLICATION OF STEM CELLS IN DISEASE TREATMENT WILL DRIVE MARKET GROWTH
    • TABLE 114 STEM CELL MANUFACTURING MARKET FOR CELL & TISSUE BANKS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 115 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR CELL & TISSUE BANKS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 116 EUROPE: STEM CELL MANUFACTURING MARKET FOR CELL & TISSUE BANKS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 117 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR CELL & TISSUE BANKS, BY COUNTRY, 2019-2026 (USD MILLION)
  • 8.6 OTHER END USERS
    • TABLE 118 STEM CELL MANUFACTURING MARKET FOR OTHER END USERS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 119 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR OTHER END USERS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 120 EUROPE: STEM CELL MANUFACTURING MARKET FOR OTHER END USERS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 121 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET FOR OTHER END USERS, BY COUNTRY, 2019-2026 (USD MILLION)

9 STEM CELL MANUFACTURING MARKET, BY REGION

  • 9.1 INTRODUCTION
    • TABLE 122 STEM CELL MANUFACTURING MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 9.2 NORTH AMERICA
    • FIGURE 23 NORTH AMERICA: STEM CELL MANUFACTURING MARKET SNAPSHOT
    • TABLE 123 NORTH AMERICA: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 124 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 125 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 126 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 127 NORTH AMERICA: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 128 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 129 NORTH AMERICA: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 130 NORTH AMERICA: STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • TABLE 131 NORTH AMERICA: STEM CELL MANUFACTURING MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • 9.2.1 US
      • 9.2.1.1 Continued focus to strengthen R&D to drive the market in the US
    • TABLE 132 US: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 133 US: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 134 US: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 135 US: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 136 US: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 137 US: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 138 US: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 139 US: STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.2.2 CANADA
      • 9.2.2.1 Rising government investment to drive the market in Canada
    • TABLE 140 CANADA: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 141 CANADA: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 142 CANADA: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 143 CANADA: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 144 CANADA: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 145 CANADA: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 146 CANADA: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 147 CANADA: STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 9.3 EUROPE
    • TABLE 148 EUROPE: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 149 EUROPE: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 150 EUROPE: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 151 EUROPE: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 152 EUROPE: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 153 EUROPE: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 154 EUROPE: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 155 EUROPE: STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • TABLE 156 EUROPE: STEM CELL MANUFACTURING MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • 9.3.1 GERMANY
      • 9.3.1.1 Strong growth in the biotechnology industry to drive market growth in the country
    • TABLE 157 GERMANY: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 158 GERMANY: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 159 GERMANY: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 160 GERMANY: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 161 GERMANY: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 162 GERMANY: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 163 GERMANY: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 164 GERMANY: STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.3.2 FRANCE
      • 9.3.2.1 Government support in stem cell manufacturing to drive the market
    • TABLE 165 FRANCE: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 166 FRANCE: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 167 FRANCE: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 168 FRANCE: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 169 FRANCE: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 170 FRANCE: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 171 FRANCE: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 172 FRANCE: STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.3.3 UK
      • 9.3.3.1 Focus on innovation will increase demand for stem-cell-based therapeutics
    • TABLE 173 UK: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 174 UK: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 175 UK: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 176 UK: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 177 UK: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 178 UK: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 179 UK: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 180 UK: STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.3.4 ITALY
      • 9.3.4.1 Initiatives encouraging the development of cell and gene therapy to boost the demand for stem cell manufacturing in the country
    • TABLE 181 ITALY: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 182 ITALY: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 183 ITALY: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 184 ITALY: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 185 ITALY: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 186 ITALY: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 187 ITALY: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 188 ITALY: STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.3.5 SPAIN
      • 9.3.5.1 Increasing funding from private and public organizations to drive the growth of the market in Spain
    • TABLE 189 SPAIN: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 190 SPAIN: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 191 SPAIN: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 192 SPAIN: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 193 SPAIN: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 194 SPAIN: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 195 SPAIN: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 196 SPAIN: STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.3.6 ROE
    • TABLE 197 ROE: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 198 ROE: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 199 ROE: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 200 ROE: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 201 ROE: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 202 ROE: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 203 ROE: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 204 ROE: STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 9.4 ASIA PACIFIC
    • FIGURE 24 ASIA PACIFIC: STEM CELL MANUFACTURING MARKET SNAPSHOT
    • TABLE 205 APAC: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 206 APAC: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 207 APAC: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 208 APAC: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 209 APAC: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 210 APAC: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 211 APAC: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 212 APAC: STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • TABLE 213 APAC: STEM CELL MANUFACTURING MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • 9.4.1 CHINA
      • 9.4.1.1 Increasing clinical trials for stem cells and innovations to drive the market
    • TABLE 214 CHINA: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 215 CHINA: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 216 CHINA: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 217 CHINA: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 218 CHINA: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 219 CHINA: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 220 CHINA: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 221 CHINA: STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.4.2 JAPAN
      • 9.4.2.1 Growing collaborations for stem cell research to drive the growth of the market in the country
    • TABLE 222 JAPAN: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 223 JAPAN: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 224 JAPAN: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 225 JAPAN: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 226 JAPAN: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 227 JAPAN: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 228 JAPAN: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 229 JAPAN: STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.4.3 INDIA
      • 9.4.3.1 The growing prevalence of chronic diseases and focus on stem cell research would drive demand in the country
    • TABLE 230 INDIA: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 231 INDIA: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 232 INDIA: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 233 INDIA: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 234 INDIA: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 235 INDIA: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 236 INDIA: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 237 INDIA: STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.4.4 REST OF ASIA PACIFIC
    • TABLE 238 ROAPAC: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 239 ROAPAC: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 240 ROAPAC: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 241 ROAPAC: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 242 ROAPAC: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 243 ROAPAC: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 244 ROAPAC: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 245 ROAPAC: STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 9.5 LATIN AMERICA
    • 9.5.1 GROWING PHARMACEUTICAL INDUSTRY IN THE REGION PROJECTED TO DRIVE THE MARKET GROWTH
    • TABLE 246 LATIN AMERICA: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 247 LATIN AMERICA: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 248 LATIN AMERICA: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 249 LATIN AMERICA: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 250 LATIN AMERICA: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 251 LATIN AMERICA: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 252 LATIN AMERICA: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 253 LATIN AMERICA: STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 9.6 MIDDLE EAST & AFRICA
    • 9.6.1 INCREASING FUNDING AND COLLABORATIONS TO DRIVE MARKET GROWTH IN THE REGION
    • TABLE 254 MEA: STEM CELL MANUFACTURING MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 255 MEA: STEM CELL MANUFACTURING MARKET FOR CONSUMABLES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 256 MEA: STEM CELL MANUFACTURING MARKET FOR INSTRUMENTS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 257 MEA: STEM CELL MANUFACTURING MARKET FOR STEM CELL LINES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 258 MEA: STEM CELL MANUFACTURING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 259 MEA: STEM CELL MANUFACTURING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 260 MEA: STEM CELL MANUFACTURING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 261 MEA: STEM CELL MANUFACTURING MARKET, BY END USER, 2019-2026 (USD MILLION)

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 KEY PLAYERS STRATEGIES/RIGHT TO WIN
    • FIGURE 25 KEY PLAYER STRATEGIES IN THE STEM CELL MANUFACTURING MARKET, 2018- 2021
  • 10.3 MARKET SHARE ANALYSIS
    • FIGURE 26 STEM CELL MANUFACTURING MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020
  • 10.4 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
  • 10.5 COMPANY EVALUATION QUADRANT
    • 10.5.1 STARS
    • 10.5.2 EMERGING LEADERS
    • 10.5.3 PERVASIVE PLAYERS
    • 10.5.4 EMERGING COMPANIES
    • FIGURE 28 STEM CELL MANUFACTURING MARKET: COMPANY EVALUATION QUADRANT, 2020
  • 10.6 COMPANY EVALUATION QUADRANT: START-UPS/SMES
    • 10.6.1 PROGRESSIVE COMPANIES
    • 10.6.2 STARTING BLOCKS
    • 10.6.3 RESPONSIVE COMPANIES
    • 10.6.4 DYNAMIC COMPANIES
    • FIGURE 29 STEM CELL MANUFACTURING MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2020
  • 10.7 PRODUCT FOOTPRINT OF COMPANIES
    • TABLE 262 PRODUCT PORTFOLIO ANALYSIS: STEM CELL MANUFACTURING MARKET (2020)
  • 10.8 GEOGRAPHIC FOOTPRINT OF COMPANIES
    • TABLE 263 GEOGRAPHIC FOOTPRINT: STEM CELL MANUFACTURING MARKET (2020)
  • 10.9 MARKET EVALUATION FRAMEWORK
    • TABLE 264 MARKET EVALUATION FRAMEWORK: PARTNERSHIPS, AGREEMENTS, JOINT VENTURES, AND COLLABORATIONS-THE MAJOR STRATEGIES ADOPTED BY PLAYERS
  • 10.10 COMPETITIVE SCENARIO
    • 10.10.1 STEM CELL MANUFACTURING MARKET: PRODUCT LAUNCHES, JANUARY 2018-APRIL 2021
    • 10.10.2 STEM CELL MANUFACTURING MARKET: DEALS, JANUARY 2018-APRIL 2021
    • 10.10.3 STEM CELL MANUFACTURING MARKET: EXPANSIONS, JANUARY 2018- APRIL 2021

11 COMPANY PROFILES

  • 11.1 KEY MARKET PLAYERS
  • (Introduction, Products offered, Recent developments, SWOT analysis, MNM view)**
    • 11.1.1 THERMO FISHER SCIENTIFIC
    • TABLE 265 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW
    • FIGURE 30 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2020)
    • TABLE 266 THERMO FISHER SCIENTIFIC: PRODUCTS OFFERED
    • 11.1.2 MERCK MILLIPORE
    • TABLE 267 MERCK MILLIPORE: BUSINESS OVERVIEW
    • FIGURE 31 MERCK MILLIPORE: COMPANY SNAPSHOT (2020)
    • TABLE 268 MERCK MILLIPORE: PRODUCTS OFFERED
    • 11.1.3 LONZA GROUP
    • TABLE 269 LONZA GROUP: BUSINESS OVERVIEW
    • FIGURE 32 LONZA GROUP AG: COMPANY SNAPSHOT (2020)
    • TABLE 270 LONZA GROUP: PRODUCTS OFFERED
    • 11.1.4 DANAHER CORPORATION
    • TABLE 271 DANAHER CORPORATION: BUSINESS OVERVIEW
    • FIGURE 33 DANAHER CORPORATION: COMPANY SNAPSHOT (2020)
    • TABLE 272 DANAHER CORPORATION: PRODUCTS OFFERED
    • 11.1.5 SARTORIUS AG
    • TABLE 273 SARTORIUS AG: BUSINESS OVERVIEW
    • FIGURE 34 SARTORIUS AG: COMPANY SNAPSHOT (2020)
    • TABLE 274 SARTORIUS AG: PRODUCTS OFFERED
    • 11.1.6 BECTON, DICKINSON AND COMPANY
    • TABLE 275 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
    • FIGURE 35 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020)
    • TABLE 276 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED
    • 11.1.7 EPPENDORF AG
    • TABLE 277 EPPENDORF AG: BUSINESS OVERVIEW
    • FIGURE 36 EPPENDORF AG: COMPANY SNAPSHOT (2019)
    • TABLE 278 EPPENDORF AG: PRODUCTS OFFERED
    • 11.1.8 CORNING INC.
    • TABLE 279 CORNING INC.: BUSINESS OVERVIEW
    • FIGURE 37 CORNING INC.: COMPANY SNAPSHOT (2020)
    • TABLE 280 CORNING INC.: PRODUCTS OFFERED
    • 11.1.9 BIO-RAD LABORATORIES
    • TABLE 281 BIO-RAD LABORATORIES: BUSINESS OVERVIEW
    • FIGURE 38 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2020)
    • TABLE 282 BIO-RAD LABORATORIES: PRODUCTS OFFERED
    • 11.1.10 TAKARA BIO GROUP
    • TABLE 283 TAKARA BIO GROUP: BUSINESS OVERVIEW
    • FIGURE 39 TAKARA BIO GROUP: COMPANY SNAPSHOT (2020)
    • TABLE 284 TAKARA BIO GROUP: PRODUCTS OFFERED
    • 11.1.11 FUJIFILM HOLDINGS CORPORATION
    • TABLE 285 FUJIFILM HOLDINGS CORPORATION: BUSINESS OVERVIEW
    • FIGURE 40 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2020)
    • TABLE 286 FUJIFILM HOLDINGS CORPORATION: PRODUCTS OFFERED
    • 11.1.12 GETINGE AB
    • TABLE 287 GETINGE AB: BUSINESS OVERVIEW
    • FIGURE 41 GETINGE AB: COMPANY SNAPSHOT (2020)
    • TABLE 288 GETINGE AB: PRODUCTS OFFERED
    • 11.1.13 TERUMO CORPORATION
    • TABLE 289 TERUMO CORPORATION: BUSINESS OVERVIEW
    • FIGURE 42 TERUMO CORPORATION: COMPANY SNAPSHOT (2020)
    • TABLE 290 TERUMO CORPORATION: PRODUCTS OFFERED
    • 11.1.14 BIO-TECHNE CORPORATION
    • TABLE 291 BIO-TECHNE CORPORATION: BUSINESS OVERVIEW
    • FIGURE 43 BIO-TECHNE CORPORATION: COMPANY SNAPSHOT (2020)
    • TABLE 292 BIO-TECHNE CORPORATION: PRODUCTS OFFERED
    • 11.1.15 HIMEDIA LABORATORIES
    • TABLE 293 HIMEDIA LABORATORIES: BUSINESS OVERVIEW
    • TABLE 294 HIMEDIA LABORATORIES: PRODUCTS OFFERED
  • 11.2 OTHER PLAYERS
    • 11.2.1 STEMCELL TECHNOLOGIES INC.
    • TABLE 295 STEMCELL TECHNOLOGIES: BUSINESS OVERVIEW
    • TABLE 296 STEMCELL TECHNOLOGIES: PRODUCTS OFFERED
    • 11.2.2 MILTENYI BIOTEC GMBH
    • TABLE 297 MILTENYI BIOTEC GMBH: BUSINESS OVERVIEW
    • TABLE 298 MILTENYI BIOTEC GMBH: PRODUCTS OFFERED
    • 11.2.3 PROMOCELL
    • TABLE 299 PROMOCELL: BUSINESS OVERVIEW
    • TABLE 300 PROMOCELL: PRODUCTS OFFERED
    • 11.2.4 ANTEROGEN CO., LTD.
    • TABLE 301 ANTEROGEN: BUSINESS OVERVIEW
    • TABLE 302 ANTEROGEN: PRODUCTS OFFERED
    • 11.2.5 CELLGENIX GMBH
    • TABLE 303 CELLGENIX GMBH: BUSINESS OVERVIEW
    • TABLE 304 CELLGENIX GMBH: PRODUCTS OFFERED
  • *Introduction, Products offered, Recent developments, SWOT analysis, MNM view might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 AVAILABLE CUSTOMIZATIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS